nano glutathione and blood brain barrier Engineered nanoplatforms for brain-targeted co-delivery of phytochemicals in Alzheimer's disease: Rational design, blood-brain penetration, multi-target therapeutic synergy Crossing the Blood–Brain Barrier: Innovations
Description
[179] found that CAP efficiently oxidized samples through nitrogen (N 2 ), reducing T-2 and HT-2 toxins to 42.24 % and 37.53 %, respectively
Notably, targeting SOD could be a promising strategy for selectively killing cancer cells [36]
[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Zhang Y., Yu L., Ao M., Jin W
The closest FDA-approved IGF-1 product is mecasermin (Increlex) , native recombinant human IGF-1, approved only for the long-term treatment of growth failure in pediatric patients with severe primary IGF-1 deficiency or GH gene deletion with neutralizing antibodies
